Markets opened mixed this morning as Canadian equities advanced while global benchmarks showed uneven performance. The TSX is up 0.77%, supported by strength in resources and financials, while the Venture Index is also higher by 0.77%. In the U.S., the Nasdaq is up nearly half a percent, but the Dow is slightly lower as investors digest stronger-than-expected GDP data. London’s FTSE is weaker, down 0.32%, as traders weigh year-end positioning.
Commodities are in focus with gold hitting a fresh record above $4,450, copper surging past $5.58, and oil holding steady. Natural gas is sharply lower, while Bitcoin trades down after recent volatility. Headlines today spotlight space and pharma, with AST SpaceMobile pulling back after Monday’s surge and Novo Nordisk jumping on U.S. approval of its Wegovy pill.
Market numbers
TSX: Up (+0.77%), 32,000.10
TSXV: Up (+0.77%), 985.54
DOW: Down (-0.05%), 48,339.75
NASDAQ: Up (+0.46%), 25,461.70
FTSE: Down (-0.32%), 9,872.5
In the headlines
- AST SpaceMobile Pulls Back: AST SpaceMobile (NDAQ: ASTS) shares fell 3% pre-market after a 14% surge Monday, driven by optimism following a U.S. executive order on space superiority.
- Novo Nordisk Jumps: Novo Nordisk (NYSE: NVO) shares surged nearly 8% after U.S. regulators approved its Wegovy pill, expanding its obesity treatment portfolio.
Currencies
USD: Up (+0.25%), $0.7289
GBP: Up (+0.04%), $0.5401
EUR: Up (+0.15%), $0.6192
JPY: Down (-0.08%), ¥114.103
AUD: Up (+0.13%), $0.91607
Bitcoin: Down (-1.25%), 120,147.1 CAD
(Conversion to C$1)
Commodities
Copper: Up (+1.25%), $5.58542
Gold: Up (+0.35%), $4,459.24
WTI: Up (+0.08%), $58.150
Natural Gas: Down (-7.27%), $3.687
To stay up-to-date on all of your market news head to Stockhouse.com.
Join the discussion: Find out what everybody’s saying about AST SpaceMobile and Novo Nordisk for December 23rd, 2025, on Stockhouse’s stock forums and message boards.
Stockhouse does not provide investment advice or recommendations. All investment decisions should be made based on your own research and consultation with a registered investment professional. The issuer is solely responsible for the accuracy of the information contained herein. For full disclaimer information, please click here.